EP Patent

EP0352781A2 — Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents

Assigned to Bristol Myers Squibb Pharma Co · Expires 1990-01-31 · 36y expired

What this patent protects

Novel aminomethyloxooxazolidinyl arylbenzene derivatives, wherein the aryl includes the phenyl, substituted phenyl, pyridyl, and substituted pyridyl groups, such as (ℓ)-N-{3-[4-(4'-pyridyl)phenyl]-2-oxooxazolidin-5-ylmethyl}acetamide, possess useful antibacterial activity.

USPTO Abstract

Novel aminomethyloxooxazolidinyl arylbenzene derivatives, wherein the aryl includes the phenyl, substituted phenyl, pyridyl, and substituted pyridyl groups, such as (ℓ)-N-{3-[4-(4'-pyridyl)phenyl]-2-oxooxazolidin-5-ylmethyl}acetamide, possess useful antibacterial activity.

Drugs covered by this patent

Patent Metadata

Patent number
EP0352781A2
Jurisdiction
EP
Classification
—
Expires
1990-01-31
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Pharma Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.